---
title: 'High-throughput quantitation of amino acids and acylcarnitine in cerebrospinal
  fluid: identification of PCNSL biomarkers and potential metabolic messengers'
date: '2023-11-29'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38028545/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1Rkszs2HVZ2RHP33OibaNFew6VK-LzjJWTD4GwmLlk8B-wCceh&fc=20220923065203&ff=20231130170641&v=2.17.9.post6+86293ac
source: (((leukemia) OR (lymphoma)) OR (myeloma)) AND (Stanford University[Affiliation])
description: 'Background: Due to the poor prognosis and rising occurrence, there is
  a crucial need to improve the diagnosis of Primary Central Nervous System Lymphoma
  (PCNSL), which is a rare type of non-Hodgkin''s lymphoma. This study utilized targeted
  metabolomics of cerebrospinal fluid (CSF) to identify biomarker panels for the improved
  diagnosis or differential diagnosis of primary central nervous system lymphoma (PCNSL).
  Methods: In this study, a cohort of 68 individuals, including patients with ...'
disable_comments: true
---
Background: Due to the poor prognosis and rising occurrence, there is a crucial need to improve the diagnosis of Primary Central Nervous System Lymphoma (PCNSL), which is a rare type of non-Hodgkin's lymphoma. This study utilized targeted metabolomics of cerebrospinal fluid (CSF) to identify biomarker panels for the improved diagnosis or differential diagnosis of primary central nervous system lymphoma (PCNSL). Methods: In this study, a cohort of 68 individuals, including patients with ...